Sotera Health Company has grown revenue 7.6% a year over three years and 6.7% a year over five. Revenue growth, 3-year annual rate: +7.6% (Diagnostics & Research median +8.4%). Revenue growth, 5-year rate: +6.7%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

SHCSotera Health Company

Healthcare

$18.06+16% 1Y

$18.06

$13.1352 weeks$19.58

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though earnings up +533% year on year.

1 good, 1 neutral, 1 without data

Revenue trend+8% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +7% a year.

Earnings trend+533% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is SHC growing?

Sotera Health Company has grown revenue 7.6% a year over three years and 6.7% a year over five.

+7.6%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +6.7%
Revenue growth, 5-year rate · +7.6% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›